Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
Clinical trial NCT07168993 · RECRUITING
Trial details
- NCT number
- NCT07168993
- Sponsor
- bioAffinity Technologies Inc.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-25
- Primary completion
- 2029-04-01
- Enrollment
- 2063
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.